· 1 min read
Hetalox specialization and why it matters
At Hetalox, we specialize in the early detection and in-depth analysis of brain atrophy using advanced AI-driven MRI analysis.
To start with a definition, cerebral atrophy, characterized by the loss of neurons and their connections, is a common feature of numerous neurodegenerative diseases, such as Alzheimer’s, multiple sclerosis, and various dementias. This atrophy can be generalized, affecting the entire brain or focal, targeting specific regions. The resulting symptoms, including memory impairment, seizures, and language disorders, significantly impact patients’ lives.
To detect those symptoms early, our team has developed state-of-the-art software that provides comprehensive volumetric assessments, delivering crucial insights into brain structure health. By benchmarking against normative data, we help patients and clinicians objectively assess how brain volumes compare to typical populations based on age and sex.
We analyze atrophy from various MRI sequences, including T1-weighted, T2-weighted, FLAIR, SWI, PD, and more. This flexibility ensures precise and thorough evaluations without the need to alter existing MRI protocols. Our detailed reports, featuring percentile rankings, enable early atrophy detection, supporting timely and accurate treatment planning. This data is essential for objective analysis and monitoring disease progression over time.
Discover more on how we are revolutionizing brain MRI analysis and helping clinicians provide better care through precise and comprehensive assessments.
Explore our demo at 👉 https://hetalox.com/demo/
